Purpose of the Test
- Monitoring the patient's response to cancer treatment.
- Early detection of cancer recurrence after treatment completion.
- Determining the extent of cancer spread in specific cases.
The Carcinoembryonic Antigen (CEA) test is a vital blood marker used to monitor cancer treatment effectiveness, particularly for colorectal cancer, and detect recurrence early to ensure proactive health management.
Scientific name: Carcinoembryonic Antigen (CEA) Test
The CEA test measures protein levels in the blood to monitor cancer patients during and after treatment. It helps doctors evaluate treatment success and detect potential cancer recurrence early.